However, in such a competitive landscape, it remains to be seen whether there will be room for all the second generation vaccines in development. For one thing, the market for boosters in high income nationsis a highly uncertain one. Scientists are still unclear whether the emergence of further variants will make regular immunisations against the virus a necessity, or whether its threat will slowly wane in the coming years.